Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al
Patients using GLP-1 medications alongside insulin or sulfonylureas (e.g., glipizide, glimepiride, glyburide) face an increased risk of hypoglycemia
* Correspondence: Walter Masson [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Tip: Opt for extra virgin olive oil whenever possible
In this post: Understanding GLP-1 Nausea: Why It Happens GLP-1 receptor agonists, used for weight loss and obesity management, work by mimicking a natural hormone that helps regulate blood sugar and appetite